Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study

Study question How safe is live attenuated influenza vaccine (LAIV), which contains egg protein, in young people with egg allergy? Methods In this open label, phase IV intervention study, 779 young people (2-18 years) with egg allergy were recruited from 30 UK allergy centres and immunised with LAIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Paul J, Southern, Jo, Andrews, Nick J, Miller, Elizabeth, Erlewyn-Lajeunesse, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673102/
https://www.ncbi.nlm.nih.gov/pubmed/26645895
http://dx.doi.org/10.1136/bmj.h6291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673102/
https://www.ncbi.nlm.nih.gov/pubmed/26645895
http://dx.doi.org/10.1136/bmj.h6291

Ejemplares similares